Literature DB >> 7710933

Induction of hepatic metallothionein I in tumour-bearing mice.

D M Kloth1, J L Chin, M G Cherian.   

Abstract

Metallothionein (MT) is an intracellular metal-binding protein which has been implicated in various biological roles, including heavy-metal detoxification and zinc and copper homeostasis, and has putative antioxidant properties. High levels of MT have been detected in certain human tumours, but its functions are unclear. The presence of tumour may cause stress conditions along with alterations in host metabolism, such as the redistribution of metals and, subsequently, in changes in hepatic MT isoforms. The distribution of basal levels of MT-1 and MT-11 isoforms in livers of different strains of mice and their induction in mice inoculated with tumour cells are investigated. While Balb-c, C57/BL and CD1 mice strains had an equal distribution of both hepatic MT isoforms, MT-I and MT-II. In addition, MT-I was the predominant isoform synthesised (> 88%) in the livers of all strains of mice at 24 h after injection with either cadmium or zinc salts. After inoculation with human testicular T7800 or T7799 tumour cells, the major form of MT induced in the livers of nude (nu/nu) mice was Zn-MT-I, and its concentration was positively correlated with the size of the inoculated tumours (r2 = 0.85). A similar positive relation was found in the livers of Balb-c mice inoculated with MM45T mouse bladder tumour cells (r2 = 0.96). Following surgical removal of T7800 tumour, hepatic MT concentrations returned to basal values. There was an increase in plasma MT levels in tumour-bearing mice and it was positively correlated with the increase in hepatic MT levels. These results demonstrate a specific increase in hepatic MT-I isoform in tumour-bearing mice, and this may be due to a generalised stress during tumour growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7710933      PMCID: PMC2033733          DOI: 10.1038/bjc.1995.139

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

Review 1.  Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.

Authors:  P A Andrews; S B Howell
Journal:  Cancer Cells       Date:  1990-02

Review 2.  Metallothionein and the trace minerals.

Authors:  I Bremner; J H Beattie
Journal:  Annu Rev Nutr       Date:  1990       Impact factor: 11.848

Review 3.  Recent developments in trace element metabolism and function: role of metallothionein in copper and zinc metabolism.

Authors:  M P Richards
Journal:  J Nutr       Date:  1989-07       Impact factor: 4.798

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 5.  Biochemistry of metallothionein.

Authors:  J H Kägi; A Schäffer
Journal:  Biochemistry       Date:  1988-11-15       Impact factor: 3.162

6.  Endotoxin induction of murine metallothionein gene expression.

Authors:  S K De; M T McMaster; G K Andrews
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

7.  Induction of hepatic metallothionein by nonmetallic compounds associated with acute-phase response in inflammation.

Authors:  K S Min; Y Terano; S Onosaka; K Tanaka
Journal:  Toxicol Appl Pharmacol       Date:  1991-10       Impact factor: 4.219

8.  Hepatic isometallothioneins in mice: induction in adults and postnatal ontogeny.

Authors:  W C Kershaw; L D Lehman-McKeeman; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1990-06-15       Impact factor: 4.219

9.  Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures.

Authors:  J J Schroeder; R J Cousins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 10.  The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells.

Authors:  M G Cherian
Journal:  Environ Health Perspect       Date:  1994-09       Impact factor: 9.031

View more
  2 in total

1.  Investigations of urinary cadmium content in patients with urinary bladder carcinoma.

Authors:  G Darewicz; E Malczyk; J Darewicz
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

2.  Experimental observations in the rat on the influence of cadmium on skin wound repair.

Authors:  A B Lansdown; B Sampson; A Rowe
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.